Neighborhood poverty and health insurance figure in late-stage diagnosis of breast cancer

March 04, 2013

Springfield, Ill., February 7, 2013 - Home may be where the heart is, but where you live could affect your health.

"Regardless of geographic location, women who live in high poverty areas or are uninsured are at greatest risk of being diagnosed with breast cancer at a later stage," said lead author Kevin Henry, Department of Geography, University of Utah.

A team of scientists was assembled by the North American Association of Central Cancer Registries (NAACCR) to examine breast cancer stage at diagnosis among 161,619 women aged 40 years and older diagnosed in ten participating US states. The team's findings are reported in the current issue of the journal Health & Place. Other studies have examined these differences, but this is one of the largest studies completed that looked at geographic predictors of late-stage breast cancer including travel time and geographic access to mammography, Henry said. The team also found that health insurance coverage and census tract poverty presented more substantial risks for late-stage diagnosis of breast cancer than geographic access.

"Based on our findings, poverty and health insurance are showing themselves to be important predictors of late stage breast cancer," said Henry, adding the study provided little evidence that geographic access measures were associated with stage at diagnosis. "While geographic barriers are an important concern when considering gaps in mammography screening and breast cancer stage at diagnosis, we need to acknowledge that there are a complex variety of other factors that can affect stage at diagnosis."

Cancer survival is poorest when the disease is found at its latest stages, which is why early detection is a critical component to improving survival and quality of life following treatment after breast cancer. "We do not currently have the tools to prevent breast cancer. But these results inform practical public health policy--focus interventions on these high risk women with the aim of reducing existing disparities in breast cancer survival," said co-author Recinda Sherman, Department of Epidemiology, University of Miami Miller Medical School.

"Quality cancer data is vital in the fight against cancer," said NAACCR's executive director Betsy Kohler. "By harnessing cancer registry data, this work has truly underscored the need for targeted interventions among uninsured women and those living in low poverty census tracts regardless of geographic location." NAACCR obtained financial support for this study from Susan G. Komen for the Cure.
-end-
Established in 1987, the North American Association of Central Cancer Registries, Inc. (NAACCR) is a collaborative umbrella organization for cancer registries, governmental agencies, professional organizations, and private groups in North America interested in enhancing the quality and use of cancer registry data. Its goal is to set standards and build consensus for the collection of uniform cancer data across the continent. All state and provincial central cancer registries in the United States and Canada are members.

North American Association of Central Cancer Registries, Inc.

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.